These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33224467)

  • 21. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission.
    Sirven JI; Sperling M; Wingerchuk DM
    Cochrane Database Syst Rev; 2001; (3):CD001902. PubMed ID: 11687000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
    Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature.
    Tang SW; Tang WH; Leonard BE
    World J Biol Psychiatry; 2019 Oct; 20(8):586-604. PubMed ID: 28649903
    [No Abstract]   [Full Text] [Related]  

  • 24. The evidence base for psychotropic drugs approved by the European Medicines Agency: a meta-assessment of all European Public Assessment Reports.
    Erhel F; Scanff A; Naudet F
    Epidemiol Psychiatr Sci; 2020 Apr; 29():e120. PubMed ID: 32336312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic and pharmacodynamic effects of psychotropic medications: Differences between sexes].
    Bergiannaki JD; Kostaras P
    Psychiatriki; 2016; 27(2):118-26. PubMed ID: 27467032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methadone at tapered doses for the management of opioid withdrawal.
    Amato L; Davoli M; Ferri M; Ali R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003409. PubMed ID: 15495052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maintenance efficacy designs in psychiatry: Randomized discontinuation trials - enriched but not better.
    Ghaemi SN; Selker HP
    J Clin Transl Sci; 2017 Jun; 1(3):198-204. PubMed ID: 29082033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Navigating the Novel Psychotropics.
    Dunlop BW
    Focus (Am Psychiatr Publ); 2021 Jan; 19(1):1-2. PubMed ID: 34483760
    [No Abstract]   [Full Text] [Related]  

  • 29. From theory to practice: challenges and rewards of implementing ketogenic metabolic therapy in mental health.
    Laurent N
    Front Nutr; 2024; 11():1331181. PubMed ID: 38389794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets.
    Anjum RL; Chandler RE; Rocca E
    Pharmaceut Med; 2022 Jun; 36(3):153-161. PubMed ID: 35486326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of lumateperone in the treatment of schizophrenia.
    Syed AB; Brašić JR
    Ther Adv Psychopharmacol; 2021; 11():20451253211034019. PubMed ID: 34377435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.
    Récalt AM; Cohen D
    Psychother Psychosom; 2019; 88(2):105-113. PubMed ID: 30893683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding.
    Hengartner MP
    Ther Adv Psychopharmacol; 2020; 10():2045125320921694. PubMed ID: 32435449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withdrawal effects confounding in clinical trials: another sign of a needed paradigm shift in psychopharmacology research.
    Cohen D; Recalt A
    Ther Adv Psychopharmacol; 2020; 10():2045125320964097. PubMed ID: 33224467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discontinuing Psychotropic Drugs from Participants in Randomized Controlled Trials: A Systematic Review.
    Cohen D; Recalt A
    Psychother Psychosom; 2019; 88(2):96-104. PubMed ID: 30923288
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.